Final rule 2026-12165
Medical Devices; Gastroenterology-Urology Devices; Classification of the Ingestible Gastrointestinal Blood Detection Capsule
The Food and Drug Administration (FDA) is classifying the ingestible gastrointestinal blood detection capsule into class II (special controls). The special controls that apply to the device type are identified in this order and will be part of the codified language for classification of the ingestible gastrointestinal blood detection capsule. We are taking this action because we have determined that classifying the device into class II will provide a reasonable assurance of safety and effectiveness of the device. We believe this action will also enhance patients' access to beneficial innovative devices, in part by reducing regulatory burdens.
Source-supplied record
Document details
- Document number
- 2026-12165
- Published
- Jun 17, 2026
- Effective
- Jun 17, 2026
- Comments close
- Not supplied
- Federal Register citation
- 91 FR 36520
Docket identifiers
- Docket No. FDA-2026-N-6536
CFR references
- Title 21, part 876